Clinical trial
A Multicenter, Randomized, Single-Blind Study Comparing the Efficacy of GrafixPRIME® to Active Comparator for the Treatment of Chronic Diabetic Foot Ulcers
NCT02675855 is registered in ClinicalTrials.gov with Osiris Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Single-Blind Study Comparing the Efficacy of GrafixPRIME® to Active Comparator for the Treatment of Chronic Diabetic Foot Ulcers
- Lead sponsor
- Osiris Therapeutics
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2016
- Completion date
- July 31, 2017
- Enrollment
- 75 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
foot ulcer, diabetic